The US supreme court has rejected an effort by anti-abortion activists to roll back access to a common abortion pill – but the battle over the pill is far from over, both in the courts and in legislatures.
In a 9-0 unanimous decision on Thursday, the US supreme court ruled that anti-abortion activists did not have standing, or the legal right to sue, over the Food and Drug Administration’s (FDA) regulation of mifepristone, one of two drugs typically used in a US medication abortion. But because the case turns on an interpretation of legal doctrine, the justices left open the possibility that someone else may challenge mifepristone in the future.
